Prestige Consumer Healthcare Inc.'s revenue was $1.09bn in fiscal 2026, down 4.3% on the year before. Since fiscal 2010 ($293m) it has grown at a compound 8.6% a year. Over the last twelve months it was $1.10bn.
Revenue history
US$ millions unless shown otherwise.
Fiscal years, plus the last twelve months (LTM) when newer.
Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.
Where the revenue comes from
Fiscal year to March 31, 2026
North American OTC Healthcare$914M
International OTC Healthcare$175M
Segments
Line of business
Revenue
Share
YoY
North American OTC Healthcare
$914M
83.9%
▼ 4.8%
International OTC Healthcare
$175M
16.1%
▼ 1.5%
Products$1.1B
Other$4M
Products and services
Line of business
Revenue
Share
YoY
Products
$1.1B
99.6%
▼ 4.6%
↳ Gastrointestinal (part of Products)
$260M
23.9%
▲ 1.5%
↳ Womens Health (part of Products)
$228M
21.0%
▼ 3.8%
↳ Eye and Ear Care (part of Products)
$143M
13.2%
▼ 22.0%
↳ Dermatologicals (part of Products)
$126M
11.6%
▼ 2.3%
↳ Analgesics (part of Products)
$114M
10.5%
▼ 3.2%
↳ Cough and Cold (part of Products)
$102M
9.4%
▼ 4.1%
↳ Oral Care (part of Products)
$101M
9.3%
▲ 6.3%
↳ Other Otc (part of Products)
$15.4M
1.4%
▲ 11.7%
Other
$4M
0.4%
▲ 235.4%
United States$850M
Outside the US$238M
Geography
Region
Revenue
Share
YoY
United States
$850M
78.1%
▼ 5.3%
Outside the US
$238M
21.9%
▼ 0.8%
From Prestige Consumer Healthcare Inc.'s 10-K filed May 14, 2026, as tagged in the filing.
View filing. Indented rows are part of the
line above; their share is of that line. In the bars, the
faint bar behind is the year before.
Revenue against peers
Pharmaceuticals: the closest covered companies by revenue. Last twelve months.
